Tradestie Institutional Equity Comparison Engine

VRAX vs VS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VRAX Overall Edge

VRAX Captures Institutional Edge (1โ€“1 Pillars ยท 4โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Virax Biolabs Group Limited Ordinary Shares (VRAX) driven by superior Momentum & Technical while VS counters with relative strength in Growth & Margin. Fundamentally, VRAX trades at N/M Forward P/E with -51515.2% operating margin (+684.9% YoY revenue) versus VS at N/M Forward P/E and -136.2% operating margin (-24.7% YoY). In options structure, VRAX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
VRAX N/M vs VS N/M Fwd P/E
Growth & Margin Winner VS
Op Margin -51515.2% vs -136.2% ยท YoY +684.9% vs -24.7%
Momentum & Technical Winner VRAX
1Y -24.6% vs -59.5% ยท 52W Pos 2% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
VRAX NASDAQ
Virax Biolabs Group Limited Ordinary Shares
In Vitro & In Vivo Diagnostic Substances
$0.33
-12.89% 1D
Market Cap $470,745
1M Return -73.13%
1Y Return -24.62%
Forward P/E N/M
Unified AI Score
46.5 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 55.0
VS NASDAQ
Versus Systems Inc. Common Stock
Services-Computer Processing & Data Preparation
$0.57
-17.44% 1D
Market Cap $4.3M
1M Return -40.83%
1Y Return -59.54%
Forward P/E N/M
Unified AI Score
40.6 / 100 SELL
Tech 25.0 Fund 47.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VRAX -24.62% VS -59.54% Spread: +34.92 pp (VRAX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VRAX TTM Op. Margin: -51515.2% VS TTM Op. Margin: -136.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VRAX vs VS. Trailing 12-month operating profitability (VRAX -51515.2% vs VS -136.2%) and valuation multiples (VRAX N/M vs VS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VRAX (4) vs VS (3)
Institutional Metric VRAX VS Criterion Row Winner
Market Capitalization Scale $470,745 $4.3M Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +684.9% -24.7% Higher Growth VRAX
Operating Margin (TTM) Profitability -51515.2% -136.2% Higher Margin VS
Net Profit Margin Profitability 0.0% -112.8% Higher Margin VRAX
Return on Equity (ROE) Capital Efficiency -78.6% -69.2% Higher ROE VS
52-Week Range Position Momentum 2% ($0โ€“$13) 0% ($1โ€“$2) Stronger Trend VRAX
Beta / 30D Volatility Risk Regime -8.20ฮฒ ยท 162% Vol 1.45ฮฒ ยท 78% Vol Lower Realized Risk VS
Unified Institutional Score Composite Signal 46.5 / 100 (HOLD) 40.6 / 100 (SELL) Higher Composite VRAX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VRAX vs VS Buy Guide
VRAX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VRAX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VRAX nor VS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.